Chair of Pharmacology, University of Melbourne
Professor Hoyer's research career can be traced from his PhD in Pharmacology (1981), DSc (1986 Strasbourg), post-doctoral work (University of Pennsylvania, Medical School, Pharmacology), via Cardiovascular Research at Sandoz (Basel, 1983) to the CNS division (1989). At Novartis, Daniel worked on both drug development and basic science projects, e.g. genomics of depression and schizophrenia (MPRC, Baltimore; Scripps & GNF, La Jolla); peptide receptors and their chemistry (European Consortium). His recent interests were in epilepsy, sleep disorders, RNAi and epigenetics. Daniel has published over 300 papers, and was one of the top 10 most cited researchers in pharmacology. He is/was a member of the British and German Pharmacological Societies, European College of Neuropsychopharmacology, Society for Neurosciences, served on the Scientific Council of Institut Pasteur and on the Council and a Director of the BPS. Daniel has served as Editor of European Journal of Pharmacology, Neuropharmacology, Current Opinion in Pharmacology, Current Drugs, Drug Discovery Today, Journal of Receptors & Signal Transduction, Pharmacology & Therapy. He is currently a Senior Editor of Psychopharmacology, Naunyn Schmiedeberg's Archives of Pharmacology, Encyclopedia of Psychopharmacology and British Journal of Pharmacology.